Muhammad Arham | AI in Drug Discovery | Innovative Research Award

Published on by Computational Biologists

Innovative Research Award

Muhammad Arham
The University of Faisalabad, Pakistan

Muhammad Arham
Affiliation The University of Faisalabad
Country Pakistan
Google Scholar tRiYSVcAAAAJ&hl
Documents 6
Citations 5
h-index 2
Subject Area AI in Drug Discovery
Event Computational Biologists Awards
ORCID 0009-0008-8496-9615

Muhammad Arham is a researcher affiliated with The University of Faisalabad whose recorded research profile is associated with artificial intelligence applications in drug discovery. Available bibliographic information identifies a Scopus author record containing two documents, two citations, and an h-index of 1. These indicators provide a limited quantitative snapshot of scholarly activity and should be interpreted in relation to publication age, field norms, and research development. [1]

Abstract

Muhammad Arham is affiliated with The University of Faisalabad, Pakistan, and has a documented research profile connected with artificial intelligence in drug discovery. His indexed record currently reports two documents, two citations, and an h-index of 1. The research area represents an interdisciplinary intersection of computational biology, artificial intelligence, pharmaceutical science, and data-driven discovery. Such approaches can support the analysis of biological and chemical information, prioritization of candidate compounds, prediction of molecular properties, and development of computational workflows for drug research. The present profile summarizes available scholarly indicators and assesses relevance to an Innovative Research Award within computational biology. [1]

Keywords

Artificial intelligence; drug discovery; computational biology; bioinformatics; machine learning; pharmaceutical research; molecular modeling; computational drug design. These keywords describe the interdisciplinary context in which artificial intelligence methods may be applied to biological and pharmaceutical research problems.

Introduction

Artificial intelligence has become an important computational approach in modern drug discovery, where large biological, chemical, and clinical datasets can be analyzed using machine learning and related computational techniques. AI-assisted workflows may contribute to target identification, compound screening, molecular property prediction, and optimization of candidate molecules. [2] Within computational biology, these methods provide a bridge between biological data interpretation and predictive computational modeling.

Research Profile

The available profile places Muhammad Arham within an interdisciplinary research environment at The University of Faisalabad, with AI in Drug Discovery identified as the principal subject area. The Scopus record associated with author ID 60694808200 contains two indexed documents and two citations, with an h-index of 1. These records establish an emerging scholarly profile, although bibliometric indicators alone cannot fully characterize methodological quality or scientific contribution. [1]

Research Contributions

Research at the intersection of artificial intelligence and drug discovery can contribute computational methods for handling complex molecular and biological datasets. Relevant approaches include machine learning models, predictive analytics, molecular representation, virtual screening, and computational prioritization of drug candidates. [2] The documented subject area therefore aligns with a broader research direction in which computational techniques are used to support pharmaceutical discovery and biological interpretation.

Publications

The available Scopus record reports two documents associated with the researcher. Because the supplied information does not provide publication titles, journals, publication years, authorship positions, or article-level DOI information, no additional publication details are inferred here. The reported document count should therefore be regarded as the bibliographic information available for this profile at the time of assessment. [1]

Research Impact

The recorded profile currently has two citations and an h-index of 1. These indicators suggest measurable but early-stage bibliometric visibility. Citation counts and h-index values can vary substantially according to discipline, publication age, database coverage, and citation practices, so they are best considered alongside qualitative evidence such as methodological originality, reproducibility, collaboration, and practical relevance. [1]

Award Suitability

The research area identified for Muhammad Arham is relevant to an Innovative Research Award because AI-driven drug discovery is a developing interdisciplinary field with applications across computational biology and pharmaceutical research. The available evidence establishes subject-area relevance and a documented scholarly record, while the limited bibliometric volume indicates that award evaluation should also consider the specific novelty, technical rigor, validation, and potential significance of the underlying research contributions. [2] Final award determination should therefore be based on the complete nomination dossier and independent assessment criteria.

Conclusion

Muhammad Arham’s documented academic profile reflects an emerging research trajectory associated with AI in Drug Discovery at The University of Faisalabad. The available bibliometric record includes two documents, two citations, and an h-index of 1. While these metrics provide a concise indication of indexed scholarly activity, they do not independently establish research quality or innovation. The profile is nevertheless thematically aligned with computational approaches to contemporary drug discovery and may be considered within an award assessment framework that evaluates substantive scientific contribution. [1]

References

  1. Journal article. (2026). Harnessing Deep Learning Models for Guide RNA Optimization and Off-Target Prediction in CRISPR Systems.
    https://doi.org/10.1002/biot.70255
  2. Google Scholar. (n.d.). Rahim Zahedi, Author ID tRiYSVcAAAAJ&hl. Google Scholar author profile.
    https://scholar.google.com/citations?user=tRiYSVcAAAAJ&hl=en
  3. Journal article. (2026). Next-Generation Artificial Intelligence Strategies for Mechanistic Cancer Target Discovery and Drug Development: A State-of-the-Art Review.
    https://doi.org/10.1016/j.drudis.2018.11.014
  4. ORCID. (n.d.). ORCID record: Muhammad Arham. ORCID.
    https://orcid.org/0009-0008-8496-9615
  5. Computational Biologists Awards. (2026.). Official award website.
    https://computationalbiologists.com/

Mukhtar Sofi | Artificial Intelligence and Computational Biology | Proteomics Research Award

Published on by Computational Biologists

Dr. Mukhtar Sofi | Artificial Intelligence and Computational Biology | Proteomics Research Award

Assistant Professor at VIT Vellore, India

Dr. Mukhtar Ahmad Sofi is an accomplished academician and researcher specializing in the intersection of artificial intelligence and bioinformatics. He currently serves as an Assistant Professor at BVRIT Hyderabad, India. With a robust foundation in computer science, Dr. Sofi’s career reflects a dedication to scientific rigor, educational excellence, and interdisciplinary innovation. His key research efforts explore machine learning, deep learning, and computational biology, particularly in protein structure prediction and biomedical data analysis. Dr. Sofi’s scholarly contributions include impactful publications in high-ranking journals, patents, and participation in global conferences. His professional journey exemplifies a commitment to scientific advancement and collaborative research leadership.

Profile

Google scholar

Education

Dr. Sofi earned his Ph.D. in Computer Science & Engineering from the University of Kashmir. He holds an M.Tech in Computer Science & Engineering and an MCA in Computer Science from Pondicherry Central University. His academic journey began with a BCA from the University of Kashmir, laying a solid foundation in computing principles. Supplementing his formal education, he pursued a Certificate in Foreign Languages (French) and completed specialized training in machine learning through the NPTEL platform from IIT Kharagpur. His academic profile demonstrates a continuous commitment to advanced learning and interdisciplinary competence.

Experience

Dr. Sofi has been working as an Assistant Professor at BVRIT Hyderabad since February 2023. His experience bridges both teaching and research, providing students with advanced training in machine learning and deep learning while leading impactful research initiatives. Before his academic appointment, he gained experience as a research fellow during his doctoral studies under the University Grants Commission’s Senior and Junior Research Fellowship schemes. Additionally, Dr. Sofi has contributed to multiple workshops, training sessions, and has mentored students to win prestigious R&D showcases. His practical experience also includes leading projects in Docker environments and leveraging deep learning libraries on NVIDIA’s DGX A100 server infrastructure.

Research Interest

Dr. Sofi’s research interests lie at the intersection of machine learning, deep learning, computational biology, and bioinformatics. His primary focus is on protein secondary structure prediction using deep learning models. He explores data partitioning strategies, convolutional and recurrent architectures, and attention mechanisms to enhance prediction accuracy. His work also expands into broader applications such as reservoir water prediction, sentiment analysis in human-robot interactions, and medical diagnostics using digital twins. Through his research, Dr. Sofi aims to bridge the gap between computational modeling and real-world biological systems, contributing to personalized medicine and AI-driven biomedical innovations.

Awards

Among Dr. Sofi’s many recognitions are the UGC-NET and JK-SET qualifications in Computer Science, both achieved in 2018. He was awarded Senior and Junior Research Fellowships by UGC for his Ph.D. studies. He received a grant of ₹3.5 lakh from AICTE to conduct an ATAL Faculty Development Program on “Generative AI: Transforming Education and Research” in 2023. He was recently selected for a prestigious Post-Doctoral Fellowship at the National University of Singapore and Chinese Academy of Medical Sciences (2024). Additionally, he received the Best Paper Presentation Award at the IEEE ICDSNS-2024 and served as a supporting trainer for NVIDIA’s advanced deep learning workshop.

Publications

Dr. Sofi’s impactful scholarly work includes the following publications:

IRNN-SS: Deep learning for optimised protein secondary structure prediction – Int. J. Bioinformatics Research and Applications, 2024. Cited by: 2.

RiRPSSP: A Unified Deep Learning method for Protein Secondary Structures – Journal of Bioinformatics and Computational Biology, 2023. Cited by: 8.

Protein secondary structure prediction using CNNs and GRUs – International Journal of Information Technology (Springer), 2022. Cited by: 14.

Smart Toll Tax Collection using BLE – International Journal of Advanced Research in Computer Science, 2017. Cited by: 5.

Bluetooth Protocol in IoT: Security Review – International Journal of Engineering Research & Technology (IJERT), 2016. Cited by: 11.

Cheating Detection in Proctored Exams using Deep Neural Networks – IEEE Access (Accepted, minor revision).

Reservoir Water Prediction using LSTM and GRU – Water Resource Management Journal (Springer) (Under review).

These publications highlight Dr. Sofi’s pioneering work in applying AI to bioinformatics and smart system solutions.

Conclusion

Dr. Mukhtar Ahmad Sofi exemplifies the future of proteomics research by merging computational intelligence with biological structure prediction. His innovative approaches, validated by high-impact publications and international recognition, significantly advance the field. Given his contributions to protein structure prediction and his visionary application of AI in bioinformatics, Dr. Sofi is an ideal recipient for the Proteomics Research Award, embodying the excellence, innovation, and interdisciplinary rigor the award stands for.